20062023
If you made any changes in Pure these will be visible here soon.

Research Output 2006 2019

2019

Cell-free DNA in cancer: current insights

Fettke, H., Kwan, E. M. & Azad, A. A., 15 Feb 2019, In : Cellular Oncology. 42, 1, p. 13-28 16 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Prognostic Utility of a Whole-blood Androgen Receptor-based Gene Signature in Metastatic Castration-resistant Prostate Cancer

Kwan, E. M., Fettke, H., Docanto, M. M., To, S. Q., Bukczynska, P., Mant, A., Pook, D., Ng, N., Graham, L. J. K., Mangiola, S., Segelov, E., Mahon, K., Davis, I. D., Parente, P., Pezaro, C., Todenhöfer, T., Horvath, L. G. & Azad, A. A., 15 May 2019, (Accepted/In press) In : European Urology Focus. 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Where to Next for Theranostics in Prostate Cancer?

Murphy, D. G., Sathianathen, N., Hofman, M. S., Azad, A. & Lawrentschuk, N., 1 Mar 2019, In : European Urology Oncology. 2, 2, p. 163-165 3 p.

Research output: Contribution to journalEditorialOtherpeer-review

Whole blood FOLH1 mRNA expression and treatment response in metastatic castration-resistant prostate cancer (mCRPC)

Kwan, E. M., To, S. Q. G., Fettke, H. C., Docanto, M., Bukczynska, P., Mant, A. M., Pook, D. W., Ng, N., Graham, L. J. K., Segelov, E., Mahon, K. L., Davis, I., Parente, P., Pezaro, C., Horvath, L. G. & Azad, A., 1 Mar 2019, In : Journal of Clinical Oncology. 37, 7 Suppl, p. 188 1 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2018

A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate

Khalaf, D. J., Avilés, C. M., Azad, A. A., Sunderland, K., Todenhöfer, T., Eigl, B. J., Finch, D., Le, L., Atwell, A., Keith, B., Kollmannsberger, C. & Chi, K. N., 1 Feb 2018, In : Canadian Urological Association. 12, 2, p. E47-E52 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Circulating tumor DNA genomics correlate with resistance to abiraterone and enzalutamide in prostate cancer

Annala, M., Vandekerkhove, G., Khalaf, D., Taavitsainen, S., Beja, K., Warner, E. W., Sunderland, K., Kollmannsberger, C., Eigl, B. J., Finch, D., Oja, C. D., Vergidis, J., Zulfiqar, M., Azad, A. A., Nykter, M., Gleave, M. E., Wyatt, A. W. & Chi, K. N., 1 Apr 2018, In : Cancer Discovery. 8, 4, p. 444-457 14 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Expression of Androgen Receptor Splice Variant 7 or 9 in Whole Blood Does Not Predict Response to Androgen-Axis–targeting Agents in Metastatic Castration-resistant Prostate Cancer

To, S. Q., Kwan, E. M., Fettke, H. C., Mant, A., Docanto, M. M., Martelotto, L., Bukczynska, P., Ng, N., Graham, L. J. K., Parente, P., Pezaro, C., Mahon, K., Horvath, L., Todenhöfer, T. & Azad, A. A., 1 Jun 2018, In : European Urology. 73, 6, p. 818-821 4 p.

Research output: Contribution to journalArticleResearchpeer-review

Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy

Lawrence, M. G., Obinata, D., Sandhu, S., Selth, L. A., Wong, S. Q., Porter, L. H., Lister, N., Pook, D., Pezaro, C. J., Goode, D. L., Rebello, R. J., Clark, A. K., Papargiris, M., Van Gramberg, J., Hanson, A. R., Banks, P., Wang, H., Niranjan, B., Keerthikumar, S., Hedwards, S. & 32 othersHuglo, A., Yang, R., Henzler, C., Li, Y., Lopez-Campos, F., Castro, E., Toivanen, R., Azad, A., Bolton, D., Goad, J., Grummet, J., Harewood, L., Kourambas, J., Lawrentschuk, N., Moon, D., Murphy, D. G., Sengupta, S., Snow, R., Thorne, H., Mitchell, C., Pedersen, J., Clouston, D., Norden, S., Ryan, A., Dehm, S. M., Tilley, W. D., Pearson, R. B., Hannan, R. D., Frydenberg, M., Furic, L., Taylor, R. A. & Risbridger, G. P., 1 Nov 2018, In : European Urology. 74, 5, p. 562-572 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial

Guo, J., Jin, J., Oya, M., Uemura, H., Takahashi, S., Tatsugami, K., Rha, S. Y., Lee, J. L., Chung, J., Lim, H. Y., Wu, H. C., Chang, Y. H., Azad, A., Davis, I. D., Carrasco-Alfonso, M. J., Nanua, B., Han, J., Ahmad, Q. & Motzer, R., 22 May 2018, In : Journal of Hematology & Oncology. 11, 1, 10 p., 69.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
2017

AR-V7 Transcripts in Whole Blood RNA of Patients with Metastatic Castration Resistant Prostate Cancer Correlate with Response to Abiraterone Acetate

Todenhöfer, T., Azad, A., Stewart, C., Gao, J., Eigl, B. J., Gleave, M. E., Joshua, A. M., Black, P. C. & Chi, K. N., 1 Jan 2017, In : Journal of Urology. 197, 1, p. 135-142 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Molecular dissection of complete response to receptor tyrosine kinase inhibition in type II papillary renal cell carcinoma

Annala, M., Nappi, L., Azad, A. A., Mo, F., Fazli, L., Chi, K. N. & Wyatt, A. W., Feb 2017, In : Clinical Genitourinary Cancer. 15, 1, p. e145-e150 6 p.

Research output: Contribution to journalArticleOtherpeer-review

2016

A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel

Chi, K. N., Kheoh, T. S., Ryan, C. J., Molina, A., Bellmunt, J., Vogelzang, N. J., Rathkopf, D. E., Fizazi, K., Kantoff, P. W., Li, J., Azad, A., Eigl, B. J. C., Heng, D., Joshua, A. M., De Bono, J. S. & Scher, H. I., 2016, In : Annals of Oncology. 27, 3, p. 454-460 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Benefit from cytoreductive nephrectomy and the prognostic role of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma

Day, D., Kanjanapan, Y., Kwan, E., Yip, D., Lawrentschuk, N., Davis, I. D., Azad, A. A., Wong, S., Rosenthal, M., Gibbs, P. & Tran, B., 1 Nov 2016, In : Internal Medicine Journal. 46, 11, p. 1291-1297 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial

Leibowitz-Amit, R., Pintilie, M., Khoja, L., Azad, A. A., Berger, R., Laird, A. D., Aftab, D. T., Chi, K. N. & Cardin, A. J., 13 Jan 2016, In : Journal of Translational Medicine. 14, 12, p. 1-8 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Continuous flow deformability-based separation of circulating tumor cells using microfluidic ratchets

Park, E. S., Jin, C., Guo, Q., Ang, R. R., Duffy, S. P., Matthews, K., Azad, A., Abdi, H., Todenhofer, T., Bazov, J., Chi, K. N., Black, P. C. & Ma, H., 13 Apr 2016, In : Small. 12, 14, p. 1909-1919 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients

Lallous, N., Volik, S. V., Awrey, S., Leblanc, E., Tse, R., Murillo, J., Singh, K., Azad, A. A., Wyatt, A. W., LeBihan, S., Chi, K. N., Gleave, M. E., Rennie, P. S., Collins, C. C. & Cherkasov, A., 26 Jan 2016, In : Genome Biology. 17, p. 1-15 15 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Genomic alterations in cell-free DNA and enzalutamide resistance in castration-resistant prostate cancer

Wyatt, A. W., Azad, A., Volik, S., Annala, M., Beja, K., McConeghy, B. J., Haegert, A., Warner, E. W., Mo, F., Brahmbhatt, S., Shukin, R., LeBihan, S., Gleave, M. E., Nykter, M., Collins, C. C. & Chi, K. N., 1 Dec 2016, In : JAMA Oncology. 2, 12, p. 1598-1606 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression

Crea, F., Quagliata, L., Michael, A., Liu, H. H. R., Frumento, P., Azad, A., Xue, H., Pikor, L. A., Watahiki, A., Morant, R., Eppenberger-Castori, S., Wang, Y., Parolia, A., Lennox, K. A., Lam, W. L., Gleave, M. E., Chi, K. N., Pandha, H. S., Wang, Y. & Helgason, C. D., May 2016, In : Molecular Oncology. 10, 5, p. 693-703 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
2015

Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel

Cheng, H. H., Gulati, R., Azad, A., Nadal, R., Twardowski, P., Vaishampayan, U. N., Agarwal, N., Heath, E., Pal, S., Rehman, H., Leiter, A., Batten, J., Montgomery, R. B., Galsky, M. D., Antonarakis, E. S., Chi, K. N. & Yu, E., 2015, In : Prostate Cancer and Prostatic Diseases. 18, 2, p. 122-127 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Androgen receptor gene aberrations in circulating cell-free DNA: Biomarkers of therapeutic resistance in castration-resistant prostate cancer

Azad, A., Volik, S., Wyatt, A. W., Haegert, A., LeBihan, S., Bell, R. H., Anderson, S., McConeghy, B. J., Shukin, R., Bazov, J., Youngren, J., Paris, P. L., Thomas, G., Small, E. J., Wang, Y., Gleave, M. E., Collins, C. C. & Chi, K. N., 2015, In : Clinical Cancer Research. 21, 10, p. 2315-2324 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma

Pal, S., Azad, A., Bhatia, S., Drabkin, H. A., Costello, B. J., Sarantopoulos, J., Kanesvaran, R., Lauer, R., Starodub, A., Hauke, R., Sweeney, C. J., Hahn, N., Sonpavde, G., Richey, S., Breen, T., Kremmidiotis, G., Leske, A. F., Doolin, E., Bibby, D., Iglesias, J. & 1 othersHutson, T. E., 2015, In : Clinical Cancer Research. 21, 15, p. 3420 - 3427 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Efficacy of enzalutamide following abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer patients

Azad, A., Eigl, B. J. C., Murray, R. N., Kollmannsberger, C. & Chi, K. N., 2015, In : European Urology. 67, 1, p. 23-29 7 p.

Research output: Contribution to journalArticleResearchpeer-review

EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma

Davis, I., Long, A., Yip, S., Espinoza, D., Thompson, J. F., Kichenadsasse, G., Harrison, M., Lowenthal, R. M., Pavlakis, N., Azad, A., Kannourakis, G., Steer, C., Goldstein, D. A., Shapiro, J., Harvie, R. M., Jovanovic, L., Hudson, A. L., Nelson, C. C., Stockler, M. R. & Martin, A. V., 2015, In : Annals of Oncology. 26, 6, p. 1118 - 1123 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Lymphadenectomy with radical cystectomy at an Australian tertiary referral institution: time trends and impact on oncological outcomes

Eapen, R., Liew, M. S., Tafreshi, A., Papa, N., Lawrentschuk, N., Azad, A., Davis, I., Bolton, D. M. & Sengupta, S., 2015, In : ANZ Journal of Surgery. 85, 7-8, p. 535-539 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Outcomes with abiraterone acetate in metastatic castration-resistant prostate cancer patients who have poor performance status

Azad, A., Eigl, B. J. C., Leibowitz-Amit, R., Lester, R., Kollmannsberger, C., Murray, R. N., Clayton, R., Heng, D., Joshua, A. M. & Chi, K. N., 2015, In : European Urology. 67, 3, p. 441-447 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Patterns of care for metastatic renal cell carcinoma in Australia

Day, D., Kanjanapan, Y., Kwan, E., Yip, D., Lawrentschuk, N., Andrews, M. C., Davis, I., Azad, A., Rosenthal, M. A., Wong, S., Johnstone, A. L., Gibbs, P. & Tran, B., 2015, In : BJU International. 116, p. 36 - 41 6 p.

Research output: Contribution to journalArticleResearchpeer-review

PD-L1 is highly expressed in Enzalutamide resistant prostate cancer

Bishop, J. L., Sio, A., Angeles, A., Roberts, M. E., Azad, A., Chi, K. N. & Zoubeidi, A., 2015, In : Oncotarget. 6, 1, p. 234-242 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Predictive and prognostic biomarkers for next-generation hormonal agents in castration resistant prostate cancer

Gleave, M., Azad, A. A., Bishop, J., Brown, M., Carver, B. S., Clarke, N., Chi, K. N., Dehm, S. M., Feng, F., Joshua, A. M., Khoja, L., Lamoureux, F., Loriot, Y., Massard, C., Miyake, H., Raj, G. V., Ravindranathan, P., Reiter, R. E., Tombal, B. & Zoubeidi, A., 2015, Medical Treatment of Urological Malignancies: International Consultation on Medical Treatment of Urological Malignancies Lisbon 2014. Stief, C., Fizazi, K. & Evans, C. (eds.). European Association of Urology, p. 435 - 441 7 p.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Other

Size and deformability based separation of circulating tumor cells from castrate resistant prostate cancer patients using resettable cell traps

Park, E. S., Duffy, S. P., Matthews, K., Ang, R. R., Todenhofer, T., Abdi, H., Azad, A., Bazov, J., Chi, K. N., Black, P. C. & Ma, H., 2015, In : Lab on a Chip. 15, 10, p. 2278 - 2286 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Targeting heat shock proteins in metastatic castration-resistant prostate cancer

Azad, A., Zoubeidi, A., Gleave, M. E. & Chi, K. N., 2015, In : Nature Reviews Urology. 12, 1, p. 26-36 11 p.

Research output: Contribution to journalArticleResearchpeer-review

2014

A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naive castration-resistant prostate cancer

Azad, A., Beardsley, E. K., Hotte, S. J., Ellard, S. L., Klotz, L., Chin, J., Kollmannsberger, C., Mukherjee, S. D. & Chi, K. N., 2014, In : Investigational New Drugs. 32, 4, p. 746 - 752 7 p.

Research output: Contribution to journalArticleResearchpeer-review

A retrospective, Canadian multi-center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration-resistant prostate cancer

Azad, A., Leibowitz-Amit, R., Eigl, B. J. C., Lester, R., Wells, J. C., Murray, R. N., Kollmannsberger, C., Heng, D., Joshua, A. M. & Chi, K. N., 2014, In : Prostate. 74, 15, p. 1544-1550 7 p.

Research output: Contribution to journalArticleResearchpeer-review

A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme

Lau, D. K., Andrews, M. C., Turner, N., Azad, A., Davis, I. & Cebon, J., 2014, In : Melanoma Research. 24, 2, p. 144 - 149 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Co-targeting deoxyribonucleic acid-dependent protein kinase and poly(adenosine diphosphate-ribose) polymerase-1 promotes accelerated senescence of irradiated cancer cells

Azad, A., Bukczynska, P. E., Haupt, Y., Cullinane, C. M., McArthur, G. A. & Solomon, B. J., 2014, In : International Journal of Radiation Oncology Biology Physics. 88, 2, p. 385 - 394 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Dexamethasone for Cancer-Related Fatigue

Franco, M., William, L., Poon, P. & Azad, A., Jan 2014, In : Journal of Clinical Oncology. 32, 6

Research output: Contribution to journalLetterOtherpeer-review

Discharge patterns, survival outcomes, and changes in clinical management of hospitalized adult patients with cancer with a do-not-resuscitate order

Azad, A., Siow, S-F., Tafreshi, A., Moran, J. & Franco, M., 2014, In : Journal of Palliative Medicine. 17, 7, p. 776 - 781 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Evaluation of prostate-specific antigen response following cessation of abiraterone acetate: Is there evidence for a withdrawal syndrome?

Azad, A. & Eigl, B. J. C., 2014, In : European Urology. 65, p. 504 - 505 2 p.

Research output: Contribution to journalLetterOtherpeer-review

Metastatic large-cell neuroendocrine prostate carcinoma: Successful treatment with androgen deprivation therapy

Azad, A. A., Jones, E. C. & Chi, K. N., 2014, In : Clinical Genitourinary Cancer. 12, 4, 3 p.

Research output: Contribution to journalArticleOtherpeer-review

Population-based impact on overall survival after the introduction of docetaxel as standard therapy for metastatic castration resistant prostate cancer

Zielinski, R. R., Azad, A., Chi, K. N. & Tyldesely, S., 2014, In : Canadian Urological Association Journal. 8, 7-8, p. 520-523 4 p.

Research output: Contribution to journalArticleResearchpeer-review

Prostate cancer - double vision but solitary lesion

Lim, H. Y., Perchyonok, Y., Fitt, G., Lokan, J., Wada, M., Fabinyi, G., Azad, A., Cher, L. & Gan, H. K., 30 Apr 2014, In : Journal of Case Reports and Studies. 2, 2, 3 p., 201.

Research output: Contribution to journalArticleOther

Open Access
File

Two decades in review: Progress in the treatment of mCRPC

Bernard, B., Azad, A. A. & Chi, K. N., 1 Aug 2014, In : Oncology Exchange: essential reading in multidisciplinary cancer care. 13, 3, p. 18-23 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Uro-oncology multidisciplinary meetings at an Australian tertiary referral centre--impact on clinical decision-making and implications for patient inclusion

Rao, K., Manya, K., Azad, A., Lawrentschuk, N., Bolton, D. M., Davis, I. & Sengupta, S., 2014, In : BJU International. 114, S1, p. 50 - 54 5 p.

Research output: Contribution to journalArticleResearchpeer-review

2013

Co-funded expanded access programmes for new oncology drugs: Creating a two-tier system for Australian cancer patients?

Azad, A. & Franco, M., Jul 2013, In : Internal Medicine Journal. 43, 7, p. 843-844 2 p.

Research output: Contribution to journalLetterOtherpeer-review

Do randomized acupuncture studies in patients with cancer need a sham acupuncture control arm?

Azad, A. & John, T., 1 Jun 2013, In : Journal of Clinical Oncology. 31, 16, p. 2057-2058 2 p.

Research output: Contribution to journalLetterOtherpeer-review

End-of-life care in oncology inpatients: Who, where, how?

Azad, A., Tafreshi, A., Siow, S. F. & Franco, M., Sep 2013, In : Journal of Oncology Practice. 9, 5, e272.

Research output: Contribution to journalLetterOtherpeer-review

Gene expression profiling of localized prostate cancer: Getting answers to the questions that really matter

Azad, A., Tran, B., Sengupta, S. & Lawrentschuk, N., 10 Sep 2013, In : Journal of Clinical Oncology. 31, 26, p. 3295-3296 2 p.

Research output: Contribution to journalLetterOtherpeer-review

Non-invasive ventilation for end-of-life oncology patients

Azad, A. & Franco, M., May 2013, In : Lancet Oncology. 14, 6, p. e199-e200 2 p.

Research output: Contribution to journalLetterOtherpeer-review

Radiation recall dermatitis induced by pazopanib

Azad, A., Maddison, C. & Stewart, J., Nov 2013, In : Onkologie. 36, 11, p. 674-676 3 p.

Research output: Contribution to journalArticleOtherpeer-review

Sonolisib: Pan-phosphatidylinositol 3-kinase (PI3K) inhibitor, Oncolytic

Azad, A. & Chi, K. N., 2013, In : Drugs of the Future. 38, 5, p. 299 - 308 10 p.

Research output: Contribution to journalArticleResearchpeer-review